12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
周五盘后交易时段，12只医疗保健类股走势
Gainers
获胜者
- Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday's after-market session. The market value of their outstanding shares is at $18.1 million.
- Benitec Biopharma (NASDAQ:BNTC) stock increased by 11.7% to $0.19. The market value of their outstanding shares is at $5.3 million.
- AlerisLife (NASDAQ:ALR) stock moved upwards by 9.09% to $0.6. The company's market cap stands at $19.5 million.
- Renalytix (NASDAQ:RNLX) shares rose 8.55% to $2.03. The company's market cap stands at $76.0 million.
- electroCore (NASDAQ:ECOR) shares increased by 8.52% to $0.28. The market value of their outstanding shares is at $19.8 million.
- Statera BioPharma (NASDAQ:STAB) stock increased by 8.37% to $0.09. The company's market cap stands at $4.8 million.
- Invacare 纽约证券交易所代码：IVC）股价在周五的盘后交易时段上涨14.3％，至0.48美元。他们已发行股票的市值为1810万美元。
- Benitec Biopharma 纳斯达克股票代码：BNTC）的股票上涨了11.7％，至0.19美元。他们已发行股票的市值为530万美元。
- AlerisLif 纳斯达克股票代码：ALR）的股票上涨了9.09％，至0.6美元。该公司的市值为1,950万美元。
- Renalytix 纳斯达克股票代码：RNLX）股价上涨8.55％，至2.03美元。该公司的市值为7,600万美元。
- 电子核心 纳斯达克股票代码：ECOR）股价上涨8.52％，至0.28美元。他们已发行股票的市值为1,980万美元。
- Statera 生物制药 纳斯达克股票代码：STAB）的股票上涨了8.37％，至0.09美元。该公司的市值为480万美元。
Losers
失败者
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares declined by 13.7% to $1.32 during Friday's after-market session. The company's market cap stands at $3.0 million.
- GreenLight Biosciences (NASDAQ:GRNA) stock declined by 10.17% to $1.06. The company's market cap stands at $160.6 million.
- Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 8.91% to $0.18. The market value of their outstanding shares is at $3.3 million.
- Baudax Bio (NASDAQ:BXRX) stock declined by 8.5% to $2.91. Trading volume for this security closed at 518.1K, accounting for 46.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 million.
- Finch Therapeutics Group (NASDAQ:FNCH) shares decreased by 8.32% to $0.44. The market value of their outstanding shares is at $21.0 million.
- Adaptimmune Therapeutics (NASDAQ:ADAP) stock declined by 7.54% to $1.35. The company's market cap stands at $221.1 million. See Also:
- 萨拉里乌斯制药 纳斯达克股票代码：SLRX）股价在周五的盘后交易时段下跌了13.7％，至1.32美元。该公司的市值为300万美元。
- 绿光生物科学 纳斯达克股票代码：GRNA）股价下跌10.17％，至1.06美元。该公司的市值为1.606亿美元。
- 智能生物解决方案 纳斯达克股票代码：INBS）股价下跌8.91％，至0.18美元。他们已发行股票的市值为330万美元。
- Baudax Bio 纳斯达克股票代码：BXRX）股价下跌8.5％，至2.91美元。该证券的交易量收于518.1K，占其过去100天平均全日交易量的46.0％。他们已发行股票的市值为160万美元。
- 芬奇疗法集团 纳斯达克股票代码：FNCH）股价下跌8.32％，至0.44美元。他们已发行股票的市值为2,100万美元。
- Adaptimmune 疗法 纳斯达克股票代码：ADAP）股价下跌7.54％，至1.35美元。该公司的市值为2.211亿美元。 另请参阅：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间